- Home
- CGBD vs BLFS Comparison
CGBD vs BLFS Comparison
Compare CGBD & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGBD
- BLFS
- Stock Information
- Founded
- CGBD 2012
- BLFS 1987
- Country
- CGBD United States
- BLFS United States
- Employees
- CGBD N/A
- BLFS N/A
- Industry
- CGBD Finance: Consumer Services
- BLFS Medical/Dental Instruments
- Sector
- CGBD Finance
- BLFS Health Care
- Exchange
- CGBD Nasdaq
- BLFS Nasdaq
- Market Cap
- CGBD 1.0B
- BLFS 1.2B
- IPO Year
- CGBD 2017
- BLFS 1989
- Fundamental
- Price
- CGBD $13.32
- BLFS $25.59
- Analyst Decision
- CGBD Hold
- BLFS Strong Buy
- Analyst Count
- CGBD 5
- BLFS 7
- Target Price
- CGBD $14.63
- BLFS $30.86
- AVG Volume (30 Days)
- CGBD 406.9K
- BLFS 423.5K
- Earning Date
- CGBD 11-04-2025
- BLFS 11-11-2025
- Dividend Yield
- CGBD 12.54%
- BLFS N/A
- EPS Growth
- CGBD N/A
- BLFS N/A
- EPS
- CGBD 1.14
- BLFS N/A
- Revenue
- CGBD $234,464,000.00
- BLFS $93,468,000.00
- Revenue This Year
- CGBD $15.09
- BLFS $26.07
- Revenue Next Year
- CGBD $6.01
- BLFS $16.86
- P/E Ratio
- CGBD $11.85
- BLFS N/A
- Revenue Growth
- CGBD N/A
- BLFS 68.16
- 52 Week Low
- CGBD $13.12
- BLFS $19.10
- 52 Week High
- CGBD $18.64
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- CGBD 34.07
- BLFS 54.16
- Support Level
- CGBD $13.22
- BLFS $25.17
- Resistance Level
- CGBD $13.91
- BLFS $27.52
- Average True Range (ATR)
- CGBD 0.22
- BLFS 0.84
- MACD
- CGBD -0.05
- BLFS -0.14
- Stochastic Oscillator
- CGBD 12.82
- BLFS 36.76
About CGBD Carlyle Secured Lending Inc.
Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.